| P50 | author | Chioma M Okeoma | Q55192647 |
| | Philip H Jones | Q61121742 |
| P2093 | author name string | Wadie D Mahauad-Fernandez | |
| P2860 | cites work | The great escape: viral strategies to counter BST-2/tetherin | Q21090506 |
| | Characterization of reemerging chikungunya virus | Q21090531 |
| | A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease | Q21559504 |
| | Human muscle satellite cells as targets of Chikungunya virus infection | Q21562321 |
| | The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infection | Q24276417 |
| | Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 |
| | Chikungunya, an epidemic arbovirosis | Q24291001 |
| | Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin | Q24294470 |
| | Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction | Q24309134 |
| | Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity | Q24312815 |
| | Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling | Q24608725 |
| | Type I IFN controls chikungunya virus via its action on nonhematopoietic cells | Q24647231 |
| | Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo | Q28510187 |
| | Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide | Q28575740 |
| | Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT | Q28730721 |
| | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu | Q29547836 |
| | Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus | Q29620003 |
| | Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage | Q31047811 |
| | In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination | Q33195882 |
| | Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies | Q33517926 |
| | BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer. | Q33631179 |
| | Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. | Q33674461 |
| | BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1) | Q33861091 |
| | ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation | Q34058142 |
| | Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 |
| | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. | Q34402446 |
| | Differential proteome analysis of chikungunya virus infection on host cells | Q34674979 |
| | Prophylaxis and therapy for Chikungunya virus infection | Q34990306 |
| | Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo | Q35518677 |
| | Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. | Q35637875 |
| | The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation | Q35838581 |
| | Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. | Q36200552 |
| | Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro | Q36356182 |
| | IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. | Q36491683 |
| | CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease | Q37314595 |
| | Nampt: linking NAD biology, metabolism and cancer | Q37334248 |
| | Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity | Q37644079 |
| | Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus | Q37660700 |
| | Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. | Q37713902 |
| | Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated BST-2/tetherin regulation | Q39096070 |
| | Stimulation of NF-κB activity by the HIV restriction factor BST2. | Q39230459 |
| | Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. | Q39243642 |
| | Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts | Q39383826 |
| | Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response | Q39881534 |
| | The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells | Q41739600 |
| | Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection | Q42091648 |
| | Development of an attenuated strain of chikungunya virus for use in vaccine production | Q44523303 |
| | Interferon-gamma protects primary monocytes against infection with human immunodeficiency virus type 1. | Q45780307 |
| | Temperature-Sensitive Mutants of Influenza Virus. I. Behavior in Tissue Culture and in Experimental Animals | Q45811202 |
| | Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation | Q57275870 |
| | Measuring number-concentrations of nanoparticles and viruses in liquids on-line | Q57797803 |
| | CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses | Q78224773 |
| | Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation | Q85444059 |
| P433 | issue | Pt 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| | chikungunya | Q243257 |
| | Chikungunya virus | Q15794049 |
| P304 | page(s) | 2450-2461 | |
| P577 | publication date | 2014-07-22 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection | |
| P478 | volume | 95 | |